60 Degrees Pharmaceuticals reported revenue of $0.21M and net income of -$2.27M for the quarter ended Jun 2026, up 106.0% year over year. This income statement covers 17 quarters of results from Jun 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||
| Revenue | 0.50M | 0.17M | 0.02M | 0.40M | 0.05M | 0.11M | 0.12M | 0.14M | 0.24M | 0.16M | 0.10M | 0.44M | 0.30M | 0.16M | 0.21M | ||
| Cost of RevenueCost of Rev | 0.09M | 0.09M | 0.16M | 0.07M | 0.18M | 0.07M | 0.15M | 0.07M | 0.09M | 0.11M | 0.12M | 0.07M | 0.05M | 0.54M | 0.12M | 0.09M | 0.15M |
| Gross Profit | 0.42M | 0.08M | -0.16M | -0.06M | -0.12M | -0.02M | -0.02M | 0.04M | 0.04M | 0.02M | 0.12M | 0.09M | 0.05M | -0.10M | 0.18M | 0.08M | 0.06M |
| Operating items | |||||||||||||||||
| Research & DevelopmentR&D | 0.23M | 0.18M | 0.05M | 0.12M | 0.20M | 0.26M | 0.10M | 0.34M | 3.10M | 0.94M | 0.61M | 0.37M | 0.23M | 0.81M | 0.64M | 0.28M | 0.60M |
| Selling, General & AdministrativeSG&A | 0.41M | 0.41M | 0.31M | 0.78M | 0.46M | 1.31M | 1.69M | 1.08M | 1.13M | 1.22M | 1.61M | 1.72M | 1.63M | 1.51M | 1.47M | 1.89M | 1.73M |
| Other Operating ExpensesOther Opex | -0.05M | -0.15M | 0.15M | 730.00 | -0.07M | 0.02M | 0.02M | ||||||||||
| Operating ExpensesOpex | 0.64M | 0.44M | 0.51M | 0.90M | 0.67M | 1.58M | 1.79M | 1.41M | 4.22M | 2.16M | 2.22M | 2.09M | 1.86M | 2.32M | 2.11M | 2.17M | 2.33M |
| Operating IncomeOp. Inc | -0.69M | -0.22M | -0.68M | -0.95M | -0.79M | -1.52M | -1.89M | -1.34M | -4.19M | -2.12M | -2.07M | -1.91M | -1.61M | -2.33M | -1.92M | -2.09M | -2.27M |
| EBIT | -0.69M | -0.22M | -0.68M | -0.95M | -0.79M | -1.52M | -1.89M | -1.34M | -4.19M | -2.12M | -2.07M | -1.91M | -1.61M | -2.33M | -1.92M | -2.09M | -2.27M |
| Non-operating items | |||||||||||||||||
| Non Operating Interest Expenses | 0.91M | 1.22M | 1.11M | 1.14M | 1.10M | 0.04M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Non Operating Investment IncomeNon-Op. Investment Inc. | -0.04M | 0.08M | -0.12M | -0.02M | |||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 5.70M | -0.15M | 1.77M | 0.01M | -0.04M | 0.02M | 0.03M | -0.13M | 0.01M | 0.00M | 0.01M | ||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.02M | 0.15M | -0.84M | 0.01M | -0.39M | 0.03M | 0.02M | 0.02M | 1.60M | 0.03M | 0.01M | 0.03M | 0.19M | 0.01M | 0.01M | ||
| Net income details | |||||||||||||||||
| EBT | -2.15M | -1.45M | -1.67M | -2.60M | -3.34M | 4.17M | -2.05M | 0.43M | -4.17M | -2.16M | -2.05M | -1.88M | -1.73M | -2.32M | -1.44M | -2.09M | -2.27M |
| Tax ProvisionsTaxes | 250.00 | 250.00 | -1.30M | 63.00 | 63.00 | 63.00 | -1.13M | 63.00 | 438.00 | 250.00 | -1.67M | 63.00 | 0.00M | 250.00 | -1.55M | ||
| Profit After TaxPAT | -2.15M | -1.46M | -1.65M | -2.60M | -3.34M | 4.19M | -2.05M | 0.43M | -4.17M | -2.16M | -2.05M | -1.88M | -1.73M | -2.32M | -1.44M | -2.09M | -2.27M |
| Income from Non-Controlling InterestsInc. Minority | -0.00M | -0.00M | 0.01M | 0.00M | -0.01M | -0.01M | 2.06M | -0.00M | -0.00M | -713.00 | -0.00M | -752.00 | -0.00M | -712.00 | -499.00 | -941.00 | -0.00M |
| Income from Continuing OperationsIncome (Continuing) | -2.15M | -1.45M | -0.37M | -2.60M | -3.34M | 4.17M | -0.92M | 0.43M | -4.17M | -2.16M | -0.38M | -1.88M | -1.74M | -2.32M | 0.11M | -2.09M | -2.27M |
| Consolidated Net IncomeConsol Net Inc. | -2.15M | -1.45M | -0.37M | -2.60M | -3.34M | 4.17M | -0.92M | 0.43M | -4.17M | -2.16M | -0.38M | -1.88M | -1.74M | -2.32M | 0.11M | -2.09M | -2.27M |
| Income towards Parent CompanyParent Net Inc | -2.15M | -1.45M | -0.37M | -2.60M | -3.34M | 4.17M | -0.92M | 0.43M | -4.17M | -2.16M | -0.38M | -1.88M | -1.74M | -2.32M | 0.11M | -2.09M | -2.27M |
| Preferred Dividend PaymentsPref Dividends | 0.10M | 0.12M | 0.12M | 0.12M | 0.12M | 0.13M | 0.12M | ||||||||||
| Net Income towards Common StockholdersNet Income | -2.15M | -1.45M | -1.66M | -2.60M | -3.34M | 4.09M | -2.08M | 0.31M | -4.29M | -2.27M | -2.18M | -2.00M | -1.74M | -2.32M | 0.11M | -2.09M | -2.27M |
| Additional items | |||||||||||||||||
| EPS (Basic) | -219.64 | -146.20 | -167.95 | -270.97 | -336.79 | 184.59 | -125.89 | 7.32 | -84.50 | -18.60 | -19.18 | -6.25 | -4.72 | -2.52 | 0.16 | -1.21 | -0.85 |
| EPS (Diluted) | -219.64 | -146.20 | -167.95 | -270.97 | -336.79 | 184.59 | -125.89 | 7.32 | -84.50 | -18.60 | -19.18 | -6.25 | -4.72 | -2.52 | 0.16 | -1.21 | -0.85 |
| Shares Outstanding | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.02M | 0.02M | 0.04M | 0.05M | 0.12M | 0.11M | 0.32M | 0.37M | 0.92M | 0.67M | 1.73M | 2.65M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.02M | 0.02M | 0.04M | 0.05M | 0.12M | 0.11M | 0.32M | 0.37M | 0.92M | 0.67M | 1.73M | 2.65M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.05M | 0.05M | 1.06M | 1.06M | 1.06M | 1.06M | 1.03M | 1.06M | 1.73M | 2.66M |
| EBITDA | -0.69M | -0.22M | -0.68M | -0.95M | -0.79M | -1.52M | -1.89M | -1.34M | -4.19M | -2.12M | -2.07M | -1.91M | -1.61M | -2.33M | -1.92M | -2.09M | -2.27M |
| Interest ExpensesInt Expense | 0.91M | 1.22M | 1.11M | 1.14M | 1.10M | 0.04M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Tax Rate | -0.01% | -0.02% | 77.73% | 0.00% | 0.00% | 0.00% | 55.22% | 0.01% | -0.01% | -0.01% | 81.54% | 0.00% | -0.09% | -0.01% | 107.52% |